Incremental Risk of Adverse Events With Oral Janus Kinase Inhibitor Use in Atopic Dermatitis and Other Indications: A Systematic Review and Meta-Analysis. J of Skin 2024, 8 (1), s320. https://doi.org/10.25251/skin.8.supp.320.